Amlodipine Besylate/Rosuvastatin Calcium/Valsartan

苯磺酸氨氯地平/瑞舒伐他汀钙/缬沙坦

Report date: 2024/11/13 20:00:43

Base Information

Drug NameAmlodipine Besylate/Rosuvastatin Calcium/Valsartan
Drug Alias NameAmlodipine/rosuvastatin/valsartanCJ-30060
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated calcium channel blockersHMG-CoA reductase inhibitors
TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channelHMG-CoA reductase
Therapy Area/IndicationsHyperlipidemiasHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes ValsartanAmlodipine BesylateRosuvastatin Calcium
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHK inno.N Corporation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHK inno.N Corporation
Active IndicationsN/A
Inactive IndicationsHyperlipidemiasHypertension

Other Information

ATC CodeN/A
Related LinksN/A